Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation

Table 1 The relationship between PSMD7 expression and clinicopathological characteristics in PC patients

Characteristics	No. of patients	PSMD7 Expression		p-value
Characteristics	No. of patients	Low n=42	High n=62	p-value
Age(years)				0.606
<60	39	17	22
≥60	65	25	40
Gender				0.339
Male	56	25	31
Female	48	17	31
Tumor size (cm)				0.025
≤3	58	29	29
>3	46	13	33
Lymph node metastasis				0.147
Negative	48	23	25
Positive	56	19	37
TNM stage				0.038
I and II	78	36	42
III and IV	26	6	20
Perineural invasion				0.056
Negative	29	16	13
Positive	75	26	49

ISSN: 2045-3701